Ekso Bionics Holdings, Inc.
EKSO
$0.4046
$0.02476.50%
| Weiss Ratings | EKSO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | EKSO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | EKSO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.43 | |||
| Price History | EKSO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -16.08% | |||
| 30-Day Total Return | -36.88% | |||
| 60-Day Total Return | -36.59% | |||
| 90-Day Total Return | -57.86% | |||
| Year to Date Total Return | -35.00% | |||
| 1-Year Total Return | -72.10% | |||
| 2-Year Total Return | -71.51% | |||
| 3-Year Total Return | -84.38% | |||
| 5-Year Total Return | -89.21% | |||
| 52-Week High % Change | -75.17% | |||
| 52-Week Low % Change | 10.50% | |||
| Price | EKSO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $1.53 | |||
| 52-Week Low Price | $0.34 | |||
| 52-Week Low Price (Date) | Mar 10, 2025 | |||
| 52-Week High Price (Date) | Apr 05, 2024 | |||
| Valuation | EKSO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 9.43M | |||
| Enterprise Value | 8.92M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.57 | |||
| Earnings Per Share Growth | -48.45% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.52 | |||
| Price/Book (Q) | 0.66 | |||
| Enterprise Value/Revenue (TTM) | 0.50 | |||
| Price | $0.40 | |||
| Enterprise Value/EBITDA (TTM) | -1.01 | |||
| Enterprise Value/EBIT | -0.85 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | EKSO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 24.64M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | EKSO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 510 984 1761 | |||
| Address | 101 Glacier Point San Rafael, CA 94901 | |||
| Website | www.eksobionics.com | |||
| Country | United States | |||
| Year Founded | 2005 | |||
| Profitability | EKSO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -58.35% | |||
| Profit Margin | -63.20% | |||
| Management Effectiveness | EKSO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -23.53% | |||
| Return on Equity | -- | |||
| Income Statement | EKSO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 17.93M | |||
| Total Revenue (TTM) | 17.93M | |||
| Revenue Per Share | $0.73 | |||
| Gross Profit (TTM) | 9.51M | |||
| EBITDA (TTM) | -8.85M | |||
| EBIT (TTM) | -10.46M | |||
| Net Income (TTM) | -11.33M | |||
| Net Income Avl. to Common (TTM) | -11.33M | |||
| Total Revenue Growth (Q YOY) | 5.01% | |||
| Earnings Growth (Q YOY) | -6.19% | |||
| EPS Diluted (TTM) | -0.57 | |||
| EPS Diluted Growth (Q YOY) | 38.80% | |||
| Balance Sheet | EKSO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 6.49M | |||
| Cash Per Share (Q) | $0.26 | |||
| Total Current Assets (Q) | 18.84M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 12.71M | |||
| Current Ratio (Q) | 2.500 | |||
| Book Value Per Share (Q) | $0.57 | |||
| Total Assets (Q) | 26.65M | |||
| Total Current Liabilities (Q) | 7.54M | |||
| Total Debt (Q) | 5.98M | |||
| Total Liabilities (Q) | 13.95M | |||
| Total Common Equity (Q) | 12.71M | |||
| Cash Flow | EKSO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -37.00K | |||
| Cash from Financing (TTM) | 7.77M | |||
| Net Change in Cash (TTM) | -2.15M | |||
| Levered Free Cash Flow (TTM) | -5.08M | |||
| Cash from Operations (TTM) | -9.85M | |||
